ArticleOncology reports2017

MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway.

Zehang Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.